Experience

• 

  Sandoz

  Jun 2007 - Jul 2008

  Technical services intern

  Analyzed control charts for various solid dosage manufacturing processes to reestablish control limits with FDA.Evaluated feasibility of automated screening and filling process for colloidal silicon dioxide.Performed dissolution studies for various capsule types.

• 

  Colorado school of mines

  Sept 2008 - May 2009

  Undergraduate research assistant

  Use of combustion synthesis to develop bone-replacement materials for use in hip implants

• 

  University of kansas

  Aug 2009 - Dec 2013

  Use of computer-aided molecular design to identify stabilizers for lyophilized protein formulations. Solution of the optimization problem focused on stochastic methods.Development and cross-validation of QSPR/QSAR models for reliable prediction of relevant properties for molecular design. Statistical methods were used to estimate the uncertainty in property prediction for computational molecular design candidates. Use of computer-aided methodologies for the combined design of ionic liquid entrainers and extractive distillation processes for the separation of azeotropes. Show less

  • Graduate Teaching Assistant

    May 2012 - Dec 2013

  • PhD Candidate and Graduate Research Assistant

    Aug 2009 - Dec 2013
• 

  Technical university of denmark

  May 2010 - Jul 2010

  Visiting scholar

  Developed thermodynamic (activity coefficient) models for ionic liquid systems. The models were implemented in ICAS software. A CAMD (computer-aided molecular design) framework was developed to select ionic liquids for use as entrainers in extractive distillation processes.

• 

  Purdue university

  Aug 2012 - Dec 2012

  Visiting scholar

  Measured aggregation following lyophilization for a variety of protein and excipient combinations. Characterized aggregation through use of UV-Vis, SEC and SDS-PAGE. Characterized lyophilized solids using pxrd. Utilized design of experiments.

• 

  Fda

  Apr 2014 - now

  I oversee the quality assessment of liquid-based generic drug products assigned to the branch, including bio INDs, Pre-ANDAs, ANDAs, and DMFs. In addition, I assist with responding to controlled correspondences. My branch is responsible for assessing a variety of complex generic products, including drug-device combination products, topical semisolids, peptides, and extended-release injectables.I am a member of the UAT for OPQ's Knowledge-Aided Assessment and Structured Application (KASA) project, working to modernize our assessments with state of the art knowledge management and analytics for better regulatory decision-making. Show less

  • Branch Chief

    Sept 2020 - now

  • Senior Chemist

    Aug 2018 - Sept 2020

  • Quality Assessment Lead (Acting)

    Jan 2017 - Sept 2020

  • Review Chemist

    Apr 2014 - Jul 2018